CIT antibody (AA 1928-2027)
Quick Overview for CIT antibody (AA 1928-2027) (ABIN564821)
Target
See all CIT AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1928-2027
-
Purpose
- Mouse polyclonal antibody raised against a partial recombinant CIT.
-
Sequence
- TYNEHITKRV ASSPAPPEGP SHPREPSTPH RYREGRTELR RDKSPGRPLE REKSPGRMLS TRRERSPGRL FEDSSRGRLP AGAVRTPLSQ VNKVWDQSSV
-
Cross-Reactivity
- Human
-
Characteristics
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- CIT (NP_009105, 1928 a.a. ~ 2027 a.a) partial recombinant protein with GST tag.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Handling Advice
- Aliquot to avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
- CIT (Citron (Rho-Interacting, serine/threonine Kinase 21) (CIT))
-
Alternative Name
- CIT
-
Background
-
Full Gene Name: citron (rho-interacting, serine/threonine kinase 21)
Synonyms: CRIK,KIAA0949,STK21 -
Gene ID
- 11113
-
NCBI Accession
- NM_007174
-
Pathways
- SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Target
-